[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334733-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334733-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-interplay-between-glioblastoma-cells-and-tumor-microenvironment-new-perspectives-for-early-diagnosis-and-targeted-cancer-therapy","The Interplay between Glioblastoma Cells and Tumor Microenvironment - New Perspectives for Early Diagnosis and Targeted Cancer Therapy","","Glioblastoma multiforme (GBM) is an aggressive primary brain tumor marked by low survival and limited treatment options dominated by chemotherapy and surgery. Molecular heterogeneity, extensive crosstalk with the tumor microenvironment (TME), and non-selective therapies promote relapse and complicate diagnosis, especially at advanced stages. Using literature data and a bioinformatic tool, the manuscript maps molecular interactions among human GBM, astrocytes, and myeloid cells, highlighting protein pathways and extracellular vesicles (EVs) with potential for targeted therapy and early diagnostic biomarkers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-interplay-between-glioblastoma-cells-and-tumor-microenvironment-new-perspectives-for-early-diagnosis-and-targeted-cancer-therapy/334733/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-interplay-between-glioblastoma-cells-and-tumor-microenvironment-new-perspectives-for-early-diagnosis-and-targeted-cancer-therapy/334733.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is early diagnosis of glioblastoma multiforme (GBM) considered crucial?","Question",{"text":63,"@type":64},"GBM is often diagnosed in advanced stages because symptoms emerge as tumors rapidly infiltrate healthy brain tissue. Early diagnosis using tumor markers and novel biomarkers is therefore essential.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What roles do molecular heterogeneity and the tumor microenvironment play in GBM outcomes?",{"text":68,"@type":64},"GBM molecular heterogeneity and complex interactions with the tumor microenvironment (TME) contribute to relapse and limit effective, selective treatments.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the manuscript connect extracellular vesicles (EVs) to potential diagnostic and therapeutic use?",{"text":72,"@type":64},"It highlights extracellular vesicles as key regulators of a microenvironment favorable to cancer progression and suggests their usefulness in identifying biomarkers for early GBM diagnosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334733,1790486681,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":4},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","brain sciences  \nReview  \nThe Interplay between Glioblastoma Cells and Tumor Microenvironment: New Perspectives for Early Diagnosis and Targeted Cancer Therapy  \nAssunta Virtuoso 1, Giuseppa D’Amico 2, Federica Scalia 2, Ciro De Luca 1, Michele Papa 1, Grazia Maugeri 3, Velia D’Agata 3, Celeste Caruso Bavisotto 2,4, * and Agata Grazia D’Amico 5  \nCitation: Virtuoso, A.; D’Amico, G.; Scalia, F.; De Luca, C.; Papa, M.; Maugeri, G.; D’Agata, V.; Caruso Bavisotto, C.; D’Amico, A.G. The Interplay between Glioblastoma Cells and Tumor Microenvironment: New Perspectives for Early Diagnosis and Targeted Cancer Therapy. Brain Sci. 2024, 14, 331. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/brainsci14040331](10.3390/brainsci14040331)  \nAcademic Editor: Álmos Klekner  \nReceived: 17 March 2024  \nRevised: 26 March 2024  \nAccepted: 28 March 2024  \nPublished: 29 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Laboratory of Neuronal Networks Morphology and System Biology, Department of Mental and Physical Health and Preventive Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy; [assunta.virtuoso@unicampania.it](assunta.virtuoso@unicampania.it) (A.V.); [ciro.deluca@unicampania.it](ciro.deluca@unicampania.it) (C.D.L.); [michele.papa@unicampania.it](michele.papa@unicampania.it) (M.P.)  \n2 Department of Biomedicine, Neurosciences and Advanced Diagnostic (BiND), Human Anatomy Section, University of Palermo, 90127 Palermo, Italy; giuseppa.damico01@unipa.it (G.D.); [federica.scalia02@unipa.it](federica.scalia02@unipa.it) (F.S.)  \n3 Department of Biomedical and Biotechnological Sciences, Section of Anatomy, Histology and Movement Sciences, University of Catania, 95100 Catania, Italy; graziamaugeri@unict.it (G.M.); vdagata@unict.it (V.D.)  \n4 Euro-Mediterranean Institute of Science and Technology (IEMEST), 90139 Palermo, Italy  \n5 Department of Drug and Health Sciences, University of Catania, 95125 Catania, Italy; agata.damico@unict.it  \n* Correspondence: [celeste.carusobavisotto@unipa.it](celeste.carusobavisotto@unipa.it)  \nAbstract: Glioblastoma multiforme (GBM) stands out as the most tremendous brain tumor, constituting 60% of primary brain cancers, accompanied by dismal survival rates. Despite advancementsin research, therapeutic options remain limited to chemotherapy and surgery. GBM molecular heterogeneity, the intricate interaction with the tumor microenvironment (TME), and non-selective treatments contribute to the neoplastic relapse. Diagnostic challenges arise from GBM advanced-stage detection, necessitating the exploration of novel biomarkers for early diagnosis. Using data from the literature and a bioinformatic tool, the current manuscript delineates the molecular interplay between human GBM, astrocytes, and myeloid cells, underscoring selected protein pathways belonging to astroglia and myeloid lineage, which can be considered for targeted therapies. Moreover, the pivotal role of extracellular vesicles (EVs) in orchestrating a favorable microenvironment for cancer progression is highlighted, suggesting their utility in identifying biomarkers for GBM early diagnosis.  \nKeywords: glioblastoma multiforme; tumor microenvironment; extracellular vesicles; chaperoning system  \n1. Introduction  \nGlioblastoma multiforme (GBM) is the most aggressive brain tumor that accounts for 60% of primary brain cancers, with a poor survival rate [1,2] . The survival time is usually less than one year after diagnosis, while for lower-grade gliomas, the survival time is longer [3] . In general, the 5-year survival rate of GBM patients remains around 10%[4] . Moreover, most patients with GBM do not h","cbCaigt0uJg9gg7W","https://ap.wps.com/l/cbCaigt0uJg9gg7W","pdf",3181635,16,"English","# Introduction\n## Glioblastoma burden and clinical limitations\n## Diagnostic challenges and imaging considerations","[{\"question\":\"Why is early diagnosis of glioblastoma multiforme (GBM) considered crucial?\",\"answer\":\"GBM is often diagnosed in advanced stages because symptoms emerge as tumors rapidly infiltrate healthy brain tissue. Early diagnosis using tumor markers and novel biomarkers is therefore essential.\"},{\"question\":\"What roles do molecular heterogeneity and the tumor microenvironment play in GBM outcomes?\",\"answer\":\"GBM molecular heterogeneity and complex interactions with the tumor microenvironment (TME) contribute to relapse and limit effective, selective treatments.\"},{\"question\":\"How does the manuscript connect extracellular vesicles (EVs) to potential diagnostic and therapeutic use?\",\"answer\":\"It highlights extracellular vesicles as key regulators of a microenvironment favorable to cancer progression and suggests their usefulness in identifying biomarkers for early GBM diagnosis.\"}]","The Interplay between Glioblastoma Cells and Tumor Microenvironment - New Perspectives for Early Diagnosis and Targeted Cancer Therapy | PDF",1790008059]